Analytical Data
-
基因名
NRSN1
- Application
-
别名
NRSN1; VMP; Neurensin-1; Neuro-p24; Vesicular membrane protein of 24 kDa; Vesicular membrane protein p24
-
种属
Human
-
表达系统
E. coli
-
标签
GST-tag at N-terminal
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q8IZ57
-
表达区间
1-195 aa
-
氨基酸序列
MSSCSNVCGSRQAQAAAEGGYQRYGVRSYLHQFYEDCTASIWEYEDDFQIQRSPNRWSSVFWKVGLISGTVFVILGLTVLAVGFLVPPKIEAFGEADFVVVDTHAVQFNSALDMYKLAGAVLFCIGGTSMAGCLLMSVFVKSYSKEEKFLQQKFKERIADIKAHTQPVTKAPGPGETKIPVTLSRVQNVQPLLAT
-
分子量
47.9 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
NRSN1 (Neuronal Regeneration Related 1) is a protein that has gained significant interest in neuroscience and regenerative medicine due to its potential role in neuronal survival and repair. Research has indicated that NRSN1 is involved in various cellular processes, including neuronal signaling, synaptic plasticity, and stress responses, highlighting its importance in maintaining neuronal health and function. Dysregulation of NRSN1 has been linked to neurodegenerative diseases and neuronal injuries, making it a target for therapeutic interventions. The recombinant expression of NRSN1 allows for the detailed study of its function and mechanisms in cellular models, facilitating the identification of pathways that could be harnessed for therapeutic purposes. Furthermore, understanding the structure-function relationship of NRSN1 through recombination techniques could lead to the development of novel strategies to promote neuronal regeneration and recovery following injury or disease. Ongoing studies aim to elucidate the specific mechanisms through which NRSN1 exerts its effects, potentially offering new insights into the treatment of conditions like Alzheimer’s disease, Parkinson’s disease, and traumatic brain injuries. The successful expression and characterization of NRSN1 in recombinant systems thus represents a promising avenue for advancing our understanding of neuronal biology and developing innovative therapeutic approaches.












